A risk management approach to the design of contraceptive implants

This data was imported from PubMed:

Authors: Rowlands, S., Sujan, M.-A. and Cooke, M.

Journal: J Fam Plann Reprod Health Care

Volume: 36

Issue: 4

Pages: 191-195

ISSN: 1471-1893

DOI: 10.1783/147118910793048593

This article assesses the risks associated with the insertion and removal of contraceptive implants. Risks to patient safety relate to the way the insertion device is designed and used, rather than to the pharmacological properties of the implant itself. Risks associated with removal are not amenable to thoughtful design. A systems approach is taken, the assumption being that human errors are symptoms of underlying systems deficiencies rather than causes of adverse events. The insertion procedure is broken down into five key steps. Errors in these steps contribute to non-insertion and deep insertion of implants. The design of the Implanon(®) applicator is critically examined and suggestions made as to how it could be improved in such a way as to reduce errors in its use. The exercise undertaken has coincided with the imminent launch of the redesigned applicator of the new contraceptive implant, Nexplanon(®). Preliminary comments are made about the new features of Nexplanon.

This source preferred by Sam Rowlands

This data was imported from Scopus:

Authors: Rowlands, S., Sujan, M.A. and Cooke, M.

Journal: Journal of Family Planning and Reproductive Health Care

Volume: 36

Issue: 4

Pages: 191-195

ISSN: 1471-1893

DOI: 10.1783/147118910793048593

This article assesses the risks associated with the insertion and removal of contraceptive implants. Risks to patient safety relate to the way the insertion device is designed and used, rather than to the pharmacological properties of the implant itself. Risks associated with removal are not amenable to thoughtful design. A systems approach is taken, the assumption being that human errors are symptoms of underlying systems deficiencies rather than causes of adverse events. The insertion procedure is broken down into five key steps. Errors in these steps contribute to non-insertion and deep insertion of implants. The design of the Implanon® applicator is critically examined and suggestions made as to how it could be improved in such a way as to reduce errors in its use. The exercise undertaken has coincided with the imminent launch of the redesigned applicator of the new contraceptive implant, Nexplanon®. Preliminary comments are made about the new features of Nexplanon. ©FSRH.

This data was imported from Europe PubMed Central:

Authors: Rowlands, S., Sujan, M.A. and Cooke, M.

Journal: The journal of family planning and reproductive health care

Volume: 36

Issue: 4

Pages: 191-195

eISSN: 2045-2098

ISSN: 1471-1893

This article assesses the risks associated with the insertion and removal of contraceptive implants. Risks to patient safety relate to the way the insertion device is designed and used, rather than to the pharmacological properties of the implant itself. Risks associated with removal are not amenable to thoughtful design. A systems approach is taken, the assumption being that human errors are symptoms of underlying systems deficiencies rather than causes of adverse events. The insertion procedure is broken down into five key steps. Errors in these steps contribute to non-insertion and deep insertion of implants. The design of the Implanon(®) applicator is critically examined and suggestions made as to how it could be improved in such a way as to reduce errors in its use. The exercise undertaken has coincided with the imminent launch of the redesigned applicator of the new contraceptive implant, Nexplanon(®). Preliminary comments are made about the new features of Nexplanon.

The data on this page was last updated at 04:55 on June 23, 2018.